A specialized forensic diagnostic protocol for detecting N-ethylpentedrone (NEPD) by targeting its specific Phase-I and Phase-II metabolic markers in urine. The approach utilizes UHPLC-QTOF-HRMS with dual-ionization to ensure comprehensive detection of both parent compounds and glucuronidated metabolites.
The SWOT analysis reveals a high-precision technical solution that solves a critical gap in NPS detection, though it is constrained by high equipment costs and a niche market. The idea's success depends on its ability to provide legally defensible evidence that general screens cannot, offsetting the high operational overhead of HRMS.
Strengths3
Weaknesses3
Opportunities3
Threats3
A SWOT analysis will help balance the technical superiority of the dual-ionization approach against the threat of rapidly evolving drug analogues. · Generated 2026-09-10 by cavi/gemma4-31b-it-awq-4bit-32kAI-generated